Patents by Inventor Tim DeZutter

Tim DeZutter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD AND SYSTEM FOR DETERMINING A RISK OF HEMODYNAMIC COMPROMISE AFTER CARDIAC INTERVENTION
    Publication number: 20220273369
    Abstract: A method and system for predicting a measure of hemodynamic compromise as a result of transcatheter cardiac treatment. The method includes providing a patient-specific anatomical model representing cardiac region and an implant model representing a three-dimensional representation of a cardiac implant. The method includes virtually deploying said implant model into said patient-specific anatomical model. A deformation of the patient-specific anatomical model is calculated as a result of implant model deployment A measure of hemodynamic compromise is determined from the virtually deployed implant model and the deformed patient-specific anatomical model.
    Type: Application
    Filed: May 14, 2022
    Publication date: September 1, 2022
    Applicant: FEops NV
    Inventors: Peter Eddy J. MORTIER, Nic DEBUSSCHERE, Gianluca DE SANTIS, Tim DeZUTTER, Matthieu Robert Anna Firmin DE BEULE
  • Method and system for determining a risk of hemodynamic compromise after cardiac intervention
    Patent number: 11331149
    Abstract: A method and system for predicting a measure of hemodynamic compromise as a result of transcatheter cardiac treatment. The method includes providing a patient-specific anatomical model representing cardiac region and an implant model representing a three-dimensional representation of a cardiac implant. The method includes virtually deploying said implant model into said patient-specific anatomical model. A deformation of the patient-specific anatomical model is calculated as a result of implant model deployment A measure of hemodynamic compromise is determined from the virtually deployed implant model and the deformed patient-specific anatomical model.
    Type: Grant
    Filed: June 28, 2021
    Date of Patent: May 17, 2022
    Assignee: FEops NV
    Inventors: Peter Eddy J. Mortier, Nic Debusschere, Gianluca De Santis, Tim DeZutter, Matthieu Robert Anna Firmin De Beule
  • METHOD AND SYSTEM FOR DETERMINING A RISK OF HEMODYNAMIC COMPROMISE AFTER CARDIAC INTERVENTION
    Publication number: 20210322103
    Abstract: A method and system for predicting a measure of hemodynamic compromise as a result of transcatheter cardiac treatment. The method includes providing a patient-specific anatomical model representing cardiac region and an implant model representing a three-dimensional representation of a cardiac implant. The method includes virtually deploying said implant model into said patient-specific anatomical model. A deformation of the patient-specific anatomical model is calculated as a result of implant model deployment A measure of hemodynamic compromise is determined from the virtually deployed implant model and the deformed patient-specific anatomical model.
    Type: Application
    Filed: June 28, 2021
    Publication date: October 21, 2021
    Applicant: FEops NV
    Inventors: Peter Eddy J. MORTIER, Nic DEBUSSCHERE, Gianluca DE SANTIS, Tim DeZUTTER, Matthieu Robert Anna Firmin DE BEULE
  • Method and system for determining a risk of hemodynamic compromise after cardiac intervention
    Patent number: 11051885
    Abstract: A method and system for predicting a measure of hemodynamic compromise as a result of transcatheter cardiac treatment. The method includes providing a patient-specific anatomical model representing cardiac region and an implant model representing a three-dimensional representation of a cardiac implant. The method includes virtually deploying said implant model into said patient-specific anatomical model. A deformation of the patient-specific anatomical model is calculated as a result of implant model deployment A measure of hemodynamic compromise is determined from the virtually deployed implant model and the deformed patient-specific anatomical model.
    Type: Grant
    Filed: August 26, 2020
    Date of Patent: July 6, 2021
    Assignee: FEops NV
    Inventors: Peter Eddy J. Mortier, Nic Debusschere, Gianluca De Santis, Tim DeZutter, Matthieu Robert Anna Firmin De Beule
  • Method and system for determining a risk of hemodynamic compromise after cardiac intervention
    Patent number: 11045256
    Abstract: A method and system for predicting a measure of hemodynamic compromise as a result of transcatheter cardiac treatment. The method includes providing a patient-specific anatomical model representing cardiac region and an implant model representing a three-dimensional representation of a cardiac implant. The method includes virtually deploying said implant model into said patient-specific anatomical model. A deformation of the patient-specific anatomical model is calculated as a result of implant model deployment A measure of hemodynamic compromise is determined from the virtually deployed implant model and the deformed patient-specific anatomical model.
    Type: Grant
    Filed: February 2, 2018
    Date of Patent: June 29, 2021
    Assignee: FEops NV
    Inventors: Peter Eddy J. Mortier, Nic Debusschere, Gianluca De Santis, Tim DeZutter, Matthieu Robert Anna Firmin De Beule
  • METHOD AND SYSTEM FOR DETERMINING A RISK OF HEMODYNAMIC COMPROMISE AFTER CARDIAC INTERVENTION
    Publication number: 20200390500
    Abstract: A method and system for predicting a measure of hemodynamic compromise as a result of transcatheter cardiac treatment. The method includes providing a patient-specific anatomical model representing cardiac region and an implant model representing a three-dimensional representation of a cardiac implant. The method includes virtually deploying said implant model into said patient-specific anatomical model. A deformation of the patient-specific anatomical model is calculated as a result of implant model deployment A measure of hemodynamic compromise is determined from the virtually deployed implant model and the deformed patient-specific anatomical model.
    Type: Application
    Filed: August 26, 2020
    Publication date: December 17, 2020
    Applicant: FEops NV
    Inventors: Peter Eddy J. MORTIER, Nic DEBUSSCHERE, Gianluca DE SANTIS, Tim DeZUTTER, Matthieu Robert Anna Firmin DE BEULE
  • Method and System for Determining a Risk of Hemodynamic Compromise After Cardiac Intervention
    Publication number: 20190357981
    Abstract: A method and system for predicting a measure of hemodynamic compromise as a result of transcatheter cardiac treatment. The method includes providing a patient-specific anatomical model representing cardiac region and an implant model representing a three-dimensional representation of a cardiac implant. The method includes virtually deploying said implant model into said patient-specific anatomical model. A deformation of the patient-specific anatomical model is calculated as a result of implant model deployment A measure of hemodynamic compromise is determined from the virtually deployed implant model and the deformed patient-specific anatomical model.
    Type: Application
    Filed: February 2, 2018
    Publication date: November 28, 2019
    Inventors: Peter Eddy J. Mortier, Nic Debusschere, Gianluca De Santis, Tim DeZutter, Matthieu Robert Anna Firmin De Beule